Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cardioplegia Solutions in CABG Surgery
NCT07386990Phase 4Completed
- Sponsor
- Region Skåne
- Start
- Jun 2021
- Primary completion
- Nov 2021
- Countries
- 1
01
Overview
Phase 4, randomised trial in Myocardial injury (2 arms), sponsored by Region Skåne. Primary endpoint: Creatine Kinase-MB at 48 hours. Started Jun 2021; status: completed.
02
Conditions
Myocardial injury
Beyond the preview
Go deeper on NCT07386990.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07386990.